Prelude Capital Management’s AfterNext HealthTech Acquisition Corp Units AFTR.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-10,799
Closed -$107K 2395
2021
Q4
$107K Sell
10,799
-256
-2% -$2.56K ﹤0.01% 1708
2021
Q3
$110K Buy
+11,055
New +$110K ﹤0.01% 1484

Other funds holding AFTR.U

Prelude Capital Management's AFTR.U Position: Q1 2022 in Review

Prelude Capital Management sold out of AfterNext HealthTech Acquisition Corp Units (AFTR.U) in Q1 2022, closing a stake of 10,799 shares — an estimated $107K sold.

Prelude Capital Management first reported a position in AFTR.U in Q3 2021 and held it in 2 quarters. The position peaked at $110K in Q3 2021. 16 funds tracked by Wall St. Rank hold AFTR.U as of Q1 2022.

  • Prelude Capital Management reported no remaining AfterNext HealthTech Acquisition Corp Units position as of Q1 2022 after selling out during the quarter.
  • Prelude Capital Management sold 10,799 AfterNext HealthTech Acquisition Corp Units shares in Q1 2022, an estimated $107K.
  • Prelude Capital Management first reported a position in AfterNext HealthTech Acquisition Corp Units in Q3 2021 and held it in 2 quarters.
  • Prelude Capital Management's AfterNext HealthTech Acquisition Corp Units position peaked at $110K in Q3 2021.
  • 16 funds tracked by Wall St. Rank held AfterNext HealthTech Acquisition Corp Units as of Q1 2022.

Based on Prelude Capital Management's 13F filing for Q1 2022, filed 16 May 2022.